for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Japan govt board: data on efficacy of COVID-19 drug candidate Avigan inconclusive

TOKYO, Dec 21 (Reuters) - The Japanese Health Ministry said on Monday its medical review board concluded that clinical trial data on Fujifilm Holdings Corp’s COVID-19 drug candidate Avigan is inconclusive to determine its efficacy.

The review board will re-examine Avigan’s effectiveness once additional data is submitted, the ministry said in a statement. (Reporting by Kiyoshi Takenaka, editing by Louise Heavens)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up